Daxor Corp. (DXR) Receives NIH Funding Notification for Landmark Multi-Center Heart Failure Trial Utilizing the BVA-100 with the United States Department of Veterans Affairs
Go back to Daxor Corp. (DXR) Receives NIH Funding Notification for Landmark Multi-Center Heart Failure Trial Utilizing the BVA-100 with the United States Department of Veterans Affairs| DAXOR CORPORATION (NASDAQ: DXR) | Delayed: 9.94 +0.14 (1.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.80 | 52 Week High | $8.90 | |||
| Open | $9.92 | 52 Week Low | $7.00 | |||
| Day High | $9.94 | P/E | N/A | |||
| Day Low | $9.92 | EPS | $-1.70 | |||
| Volume | 1,010 | |||||
